Technology
100 Most Popular
Health

Tilray

$45.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.93 (-4.06%) Today
+$0.09 (0.20%) After Hours

Why Robinhood?

You can buy or sell Tilray and other stocks, options, ETFs, and crypto commission-free!

About

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. Its products include dried cannabis and cannabis extracts. Read More The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

Employees
688
Headquarters
Nanaimo, British Columbia
Founded
2018
Market Cap
4.25B
Price-Earnings Ratio
Dividend Yield
Average Volume
4.23M
High Today
$48.45
Low Today
$45.50
Open Price
$47.16
Volume
605.25K
52 Week High
$300.00
52 Week Low
$20.10

Collections

Technology
100 Most Popular
Health
Biotechnology
Medical
2018 IPO
Canada
North America

News

BenzingaMay 17

Cramer To Cannabis Investors: Be Cautious With 'Promotional' Executives

As is the case in any industry, some companies are simply better than others. This logic holds true in the cannabis space, where only some companies boast ample capital and are backed by a strong management team, CNBC's Jim Cramer said during his daily "Mad Money" show Thursday. Other companies have simply become "too promotional for my taste," he said. What Happened Shares of Tilray Inc (NASDAQ: TLRY) briefly soared from $100 to $300 per share ahead of recreational legalization in Canada, Cramer said. S...

3,555
BenzingaMay 15

Tilray CEO On Cannabis Company's Q1: 'Our Objective Is To Invest For The Long-Term'

Tilray Inc (NASDAQ: TLRY) reported Tuesday with first-quarter results that were highlighted by a 195-percent jump in revenue year-over-year — and show the long-term opportunity within the cannabis space, CEO Brendan Kennedy told CNBC following the earnings release.

3,753
Barron'sMay 15

Tilray Stock Is Falling Even Though the Marijuana Grower Posted Strong Revenue

Text size Canadian marijuana grower Tilray reported a larger loss than Wall Street expected and shares were trading down Wednesday morning after rising in aftermarket trading on Tuesday. The company’s better than expected revenue had helped push the volatile stock higher. Here is what some analysts said about Tilray’s (ticker: TLRY) latest quarter, and its prospects. BMO Capital Markets analyst Tamy Chen upgraded her rating of Tilray to Market Perform from Underperform. She wrote that the first quarter w...

2,935

Earnings

-$0.33
-$0.25
-$0.16
-$0.08
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.27 per share
Actual
-$0.27 per share

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.